- cafead May 26, 2023 at 10:02: AM
via Tim Springer never dreamed he’d be spending as much time investing in biotechnology companies as on his academic pursuits.
Springer, after all, is a leading scientist in research on proteins known as “integrins.” For more than four decades at his Harvard University laboratory, he has studied the role the complex molecules play and how they might be targeted to treat disease.
article source
Springer, after all, is a leading scientist in research on proteins known as “integrins.” For more than four decades at his Harvard University laboratory, he has studied the role the complex molecules play and how they might be targeted to treat disease.
article source